Alcohol Use Disorder, Contingency Management
Conditions
Brief summary
Contingency management (CM) is highly efficacious for reducing substance use, and recent data suggest that reinforcing attendance at treatment can significantly improve treatment outcomes. Importantly, CM interventions that reinforce attendance are more likely to be adopted clinically than those that reinforce abstinence. Having objective indicators of drinking outcomes, nevertheless, is critical for quantifying the benefits of attendance-based CM treatment in alcohol abusing populations. New technology is now available to gauge alcohol use in patients' natural environments. The Secure Continuous Remote Alcohol Monitor (SCRAMx®) continuously monitors alcohol consumption 24 hours a day. As such, it may be ideal for objective evaluation of alcohol consumption during treatment intervention studies, including those that involve CM. In this study, 114 patients participating in community based outpatient treatment programs for alcohol use disorders will wear SCRAMx for a 12-week period. They will be randomized to standard care or standard care plus CM, with reinforcement contingent upon attendance at treatment. The investigators will assess treatment attendance and alcohol use via SCRAMx and self reports. The investigators expect that patients randomized to the CM intervention will remain in treatment longer and show reductions in both SCRAMx assessed and self reported drinking days relative to those randomized to standard care.
Interventions
BEHAVIORALprize contingency management for attending treatment
BEHAVIORALusual care
Sponsors
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
UConn Health
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* age 18 years or older * current diagnosis of alcohol use disorder * able to pass an informed consent quiz * agree to wear a SCRAMx monitor for 12 weeks * have a standard, SCRAMx compatible phone line in their home or agree to attend the clinic at least every other week for data downloads * agree to sign an off-campus property transfer form and return SCRAMx equipment in 12 weeks
Exclusion criteria
* serious, uncontrolled psychiatric illness * in recovery from pathological gambling * unstable address * intend to participate in activities incompatible with SCRAMx in the next 3 months * are wearing SCRAMx for legal purposes
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| longest duration of actively attending treatment | 3 months | patient attendance to treatment groups as verified by clinic records (number of days attended out of number of days expected to treatment) |
Countries
United States
Outcome results
None listed